Executive Summary Chinese Crop Protection (CP) innovators are entering a different phase of globalization. While China-origin science is increasingly credible, a harder question is how to turn a promising asset - molecule, formulation or technology - into durable global value. China biopharma...

White Paper Series | March 2026 This white paper is written for leaders of China’s leading crop protection companies that have already built global export scale, but now face a harder question: how to convert volume leadership into durable global value pools under tighter regulation, China+1...

For crop protection multinationals, China has long mattered in two ways: as a major end-market and as a critical manufacturing and sourcing base. That is still true. In 2023, China remained the world’s third-largest crop protection market by value at nearly USD 8.0 billion. It is also still...

How input firms are adapting to mature markets Across Asia, many mature agri‑inputmarkets face slower top‑line growth, rising execution costs, and growing competition from regional players and generics. Simply selling more products doesn’t work when market demand is flattening and margins are...